You just read:

BioVentrix Announces First Patient Enrolled in IDE Study of the Revivent TC™ TransCatheter Ventricular Enhancement Treatment for Ischemic Cardiomyopathy

News provided by

BioVentrix Inc.

Aug 21, 2017, 01:00 ET